 This study is part of a national multicenter study NOR-DMARD that aims to measure the longterm safety and effectiveness of disease modifying therapies in inflammatory arthropathies. The Nor-Dmard study is a comparative, phase IV, longitudinal, observational study. All patients starting a DMARD regime are enrolled. Patients from two clinics different parts of Norway will be randomised to receive follow-up care from either a clinical nurse or a rheumatologist. 